Vulnerabilities

Vulnerability · CVE-2025-43794

Stored cross-site scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7

Published Sep 15, 2025 · catalog updated Sep 15, 2025 · Liferay DXP

Check if you run it

No confirmed exploitation is on record for CVE-2025-43794. EPSS is 0.23%. Act only if a listed version of Liferay DXP is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium4.6
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.23%
Remediation
Advisory link
Affected products
vendor Liferay DXP 2023.Q4.0

Stored cross-site scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions allows remote authenticated attackers with the instance administrator role to inject arbitrary web script or HTML into all pages via a crafted payload injected into the Instance Configuration's (1) CDN Host HTTP text field or (2) CDN Host HTTPS text field.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Liferay DXP 2023.Q4.02023.Q4.0

How to fix CVE-2025-43794

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-43794. EPSS is 0.23%. Act only if a listed version of Liferay DXP is installed.

Which versions are affected?

Compare what you have installed with Liferay DXP 2023.Q4.0 2023.Q4.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.23%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Sep 15, 2025 · EUVD

    Detected

    Stored cross-site scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions allows remote authenticated attackers with the instance administrator role to inject arbitrary web script or HTML into all pages via a cra

  2. Sep 15, 2025 · EUVD

    Updated

    Stored cross-site scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions allows remote authenticated attackers with the instance administrator role to inject arbitrary web script or HTML into all pages via a cra

Sources

  • CVE.orgVulnerability recordCVE-2025-43794

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-43794

    30-day exploitation probability 0.23%

    first.org
  • EUVDVulnerability recordEUVD-2025-29168

    Stored cross-site scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions allows remote auth

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 23, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.